SSAC:LSE:LSE-iShares MSCI ACWI UCITS ETF USD (Acc) GBP (GBX)

ETF | Others |

Last Closing

USD 6884

Change

+42.00 (+0.61)%

Market Cap

N/A

Volume

0.07M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNIF:LSE Xtrackers Nifty 50 Swap UCITS ..

+162.50 (+0.83%)

USD 292,109.69B
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

+2.20 (+0.87%)

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

+2.25 (+1.17%)

USD 1,607.29B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.08 (+0.41%)

USD 701.81B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.10 (+0.66%)

USD 636.56B
0R1I:LSE NVIDIA Corp.

-0.53 (-0.45%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-0.95 (-1.36%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

+0.18 (+0.57%)

USD 260.39B
0QZO:LSE 0QZO

+1.30 (+1.31%)

USD 258.54B

ETFs Containing SSAC:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.31% 26% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -3.31% 25% F 33% F
Trailing 12 Months  
Capital Gain 8.38% 64% D 62% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 8.38% 62% D 61% D-
Trailing 5 Years  
Capital Gain 105.43% 70% C- 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 105.43% 68% D+ 73% C
Average Annual (5 Year Horizon)  
Capital Gain 12.84% 71% C- 73% C
Dividend Return 12.84% 70% C- 72% C
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.07% 64% D 79% B-
Risk Adjusted Return 115.97% 95% A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike